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ABSTRACT
Introduction Value- based healthcare delivery models 
have emerged to address the unprecedented pressure on 
long- term health system performance and sustainability 
and to respond to the changing needs and expectations 
of patients. Implementing and scaling the benefits from 
these care delivery models to achieve large- system 
transformation are challenging and require consideration 
of complexity and context. Realist studies enable 
researchers to explore factors beyond ‘what works’ 
towards more nuanced understanding of ‘what tends to 
work for whom under which circumstances’. This research 
proposes a realist study of the implementation approach 
for seven large- system, value- based healthcare initiatives 
in New South Wales, Australia, to elucidate how different 
implementation strategies and processes stimulate the 
uptake, adoption, fidelity and adherence of initiatives to 
achieve sustainable impacts across a variety of contexts.
Methods and analysis This exploratory, sequential, 
mixed methods realist study followed RAMESES II 
(Realist And Meta- narrative Evidence Syntheses: Evolving 
Standards) reporting standards for realist studies. Stage 
1 will formulate initial programme theories from review 
of existing literature, analysis of programme documents 
and qualitative interviews with programme designers, 
implementation support staff and evaluators. Stage 
2 envisages testing and refining these hypothesised 
programme theories through qualitative interviews 
with local hospital network staff running initiatives, 
and analyses of quantitative data from the programme 
evaluation, hospital administrative systems and an 
implementation outcome survey. Stage 3 proposes 
to produce generalisable middle- range theories by 
synthesising data from context–mechanism–outcome 
configurations across initiatives. Qualitative data 
will be analysed retroductively and quantitative data 
will be analysed to identify relationships between 
the implementation strategies and processes, and 
implementation and programme outcomes. Mixed methods 
triangulation will be performed.
Ethics and dissemination Ethical approval has been 
granted by Macquarie University (Project ID 23816) 
and Hunter New England (Project ID 2020/ETH02186) 
Human Research Ethics Committees. The findings will be 
published in peer- reviewed journals. Results will be fed 
back to partner organisations and roundtable discussions 




Globally, healthcare systems face unprece-
dented pressures on long- term performance 
and sustainability.1–3 Substantial challenges 
include the ageing of populations, growing 
Strengths and limitations of this study
 ► Each of the value- based healthcare initiatives are 
based on evidence- informed clinical models of care, 
allowing our investigation to focus on understanding 
of the implementation strategies and processes that 
facilitate effective adoption and scaling.
 ► These seven natural experiments span many sites 
and patient conditions, creating the opportunity to 
explore diverse implementation strategies across a 
variety of settings.
 ► This research envisages a realist study, a method-
ological approach to provide a deep understanding 
of how complex implementation strategies and 
processes achieve a variety of outcomes for dif-
ferent populations, given varied circumstances and 
timelines.
 ► This study uses a mixed methods design to cre-
ate optimal conditions for iterative exploration and 
rigour when developing programme implementation 
theories.
 ► Some assumptions may need to be made for the use 
of retrospective data to complement prospectively 
collected data, which potentially represents a lim-
itation pending the direction and level of uncertainty 
surrounding these assumptions.
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prevalence of chronic conditions, increased rates of 
hospital utilisation, rising costs of new medical tech-
nologies and medicines, and inefficient allocation of 
scarce resources.4–6 Healthcare spending consumes an 
increasingly large proportion of government expendi-
ture worldwide,7 without always delivering commensurate 
improvements in outcomes.8 This is evidenced by only 
around 60% of care aligning with current evidence, 30% 
considered low value and 10% resulting in harm.9 Further, 
patient expectations of healthcare are rising, and there 
is a developing understanding for how subjective patient 
outcomes, such as satisfaction and experience, can influ-
ence how people use the system and benefit from it.10 11 
In response, governments and policy makers have turned 
their focus to optimising access, efficiency and quality of 
care through system- wide transformation.12–15
Value-based healthcare
Value- based healthcare, a concept that has received 
substantial attention recently, is described as a shift away 
from ‘volume- oriented’ systems (activity as a primary 
measure of performance) towards those that addition-
ally focus on the ’value’ of outcomes achieved.16 17 The 
core principles of value- based healthcare in New South 
Wales (NSW), Australia, expressly ‘considers what value 
means for patients, clinicians and the health system, and 
aims to provide health services that deliver value across 
four domains: improved health outcomes; improved 
experiences of receiving care; improved experiences of 
providing care; and better effectiveness and efficiency 
of care’.18 These principles are considered compatible 
with ensuring system sustainability, while keeping patient- 
centred care front of mind.18 How to best generate value 
is expressed differently throughout the academic litera-
ture,19–21 and is unlikely to be entirely achieved by realign-
ment of healthcare funding models alone. Efforts to date 
have largely focused on implementing evidence- based 
models that attempt to align delivery of the right care in 
the right setting at the right time, to reduce unwarranted 
practice variation and to promote patient- centred care.18
In NSW, Australia, the orientation towards value- based 
healthcare is focused on the ‘quadruple aim’ approach 
that prioritises resources towards improving population 
health, improving the experience of those receiving and 
providing care, and managing available resources and 
the per capita costs of care.22 There are several state- 
wide programmes designed to scale and support change 
through a range of system- wide approaches for targeted 
cohorts of people. Leading Better Value Care (LBVC) is 
one of those programmes and is positioned as a value- 
based healthcare programme for specific conditions that 
commenced public health system- wide implementation 
across over 100 health facilities in NSW from 2017 to 
2018. The principles of the programme involve clinicians, 
networks and organisations implementing best- practice, 
value- based care, and treatment and management for 
chronic conditions.23 Seven of the eight Tranche One 
LBVC initiatives have been identified as having a high 
potential to avoid unnecessary hospitalisation (which 
is a focus of this work) and are supported by multiple 
organisations, including the NSW Ministry of Health at 
the macro- level, and the Agency for Clinical Innovation 
(ACI), Bureau of Health Information and the Clinical 
Excellence Commission at the meso- level. Further details 
regarding the aims of each initiative are provided in 
table 1.
While the initiatives focus on the organisation and 
delivery of care for specific patient cohorts, the overar-
ching implementation strategies are based on guiding 
principles that span across the initiatives. The initia-
tives aim to create shared priorities between healthcare 
organisations, through an alignment framework that 
monitors care processes and outcomes against best- 
practice guidelines. NSW hospital networks (encom-
passing public hospitals, health institutions and services 
to defined geographical areas of the State, referred to as 
Local Health Districts) are responsible for designing local 
improvement plans that involve executive sponsorship, 
governance and leadership structures. Underpinning the 
implementation of the LBVC programme are resources 
provided by the supporting organisations in the form of 
project management, system- level enablers, funding for 
local implementation, an online collaboration portal, as 
part of a multilevel implementation package outlined in 
table 2. While the LBVC projects seek to focus on best 
clinical practice and value- based care,18 the important 
variations in context and how these interact with change 
mechanisms that drive implementation outcomes present 
unique challenges for the implementation of this system- 
wide programme at scale. This information is important 
in guiding how similar large- system projects can be scaled 
up and replicated in other local contexts.
Implementation and scaling of value-based care initiatives
The LBVC initiatives seek to accelerate best clinical 
practice and value- based care but the challenge lies in 
identifying how best to implement change at scale in 
complex adaptive healthcare systems. Healthcare systems 
are complex, adaptive, dynamic webs of vast numbers of 
interactions between healthcare professionals, adminis-
trators, support staff, patients, their families and a multi-
tude of associated stakeholders.24–26 There are few linear 
pathways, making implementation of any project a chal-
lenging endeavour. Along with the multitude of factors 
and interactions encountered when navigating complex 
healthcare systems, multiple aspects of implementation 
must also be considered. Much research effort is devoted 
to building the evidence base for particular models of 
care, in the form of clinical efficacy and effectiveness.27 
However, less focus is paid to improving implementation 
outcomes, distinct from service system outcomes and 
clinical treatment outcomes, that measure the effects 
of deliberate and purposive actions to implement new 
treatments, practices and services.28 These measures 
focus on the acceptability, adoption, appropriateness, 
implementation costs, feasibility, fidelity, penetration and 
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Table 1 Description of the seven Tranche One LBVC initiatives




People with diagnosed 
osteoarthritis of the knee or hip
Aims to improve daily function and delay, avoid or improve recovery 
from knee or hip joint replacement surgery. The initiative involves 
expanding outpatient- based multidisciplinary conservative treatment 
options and support self- management strategies, including exercise, 





People aged 50 years and older 
who present to hospital with 
osteoporotic fracture
Aims to prevent refractures for people with osteoporosis by improving 
identification of conditions underlying minimal trauma fractures and 
streamlining case management processes. The initiative includes case 
management that supports patient access to medical consultations, 
community- based care and refracture education. Enhancing primary 
care management and fewer refractures is oriented towards reducing 
hospital admissions.
Chronic heart failure People aged over 18 years, 
admitted with symptoms 
suggestive of chronic heart failure
Aims to reduce 28- day readmission and 30- day mortality by a focus 
on reducing unwarranted variation from best practice, enhance 
prevention, improve the management and mitigation of risks for people 
with chronic heart failure. These aims are to be achieved by improving 
early, accurate diagnosis, exacerbation management, transfer of 
care to multidisciplinary teams and palliative care. Multidisciplinary 
coordination of acute and primary care is leveraged to support self- 




Acute admitted patients aged 40 
years and older with COPD
Aims to reduce 28- day readmission and 30 day mortality by a focus 
on reducing unwarranted clinical variation and optimise lung function 
for people with COPD, with the goal of preventing deterioration that 
leads to acute episodes and hospital admission. The initiative involves 
patient education, chronic disease self- management and pulmonary 




Acute admitted patients aged 
16 years and older with diabetes 
requiring subcutaneous insulin 
management
Glycaemic instability puts inpatients with diabetes at greater 
risk of infections and other complications. This initiative aims to 
reduce the length of hospital admission for people with diabetes 
requiring subcutaneous insulin management by optimising glucose 
management. The initiative involves improving capacity to manage 
insulin and glucose among junior medical officers and general ward 
staff, and access to inpatient diabetes management teams, including 
safe transfers and standardised identification processes.
Diabetes high- risk 
foot service
People over 15 years of age with 
diabetic foot- related infections 
and/or ulcers of the foot or lower 
limb, including diabetes- related 
foot ulceration, infection and 
acute Charcot’s neuropathy
Aims to improve treatment and patient outcomes and reduce 
complications and associated hospitalisations for people with diabetic 
foot- related infections and/or ulcers of the foot or lower limb by 
enhancing equitable access to best- practice preventative care and 
management. The initiative involves outpatient- based high- risk foot 
services incorporating a multidisciplinary team approach and following 




People with chronic kidney 
disease or end- stage kidney 
disease deciding whether 
to pursue renal replacement 
therapies (RRT), conservatively 
managed without RRT, receiving 
RRT but experiencing symptoms 
impacting quality of life, and 
those withdrawing from dialysis
Aims to enhance patient (and carer) experience by supporting 
outpatient- based symptom management and palliative care for people 
with chronic and end- stage kidney disease. The initiative involves the 
Renal Supportive Care model of patient (and carer) support regardless 
of whether they embark on, or cease, RRT, backed by advanced and 
palliative care planning.
Source: Adapted and reproduced with permission from NSW Health, Leading Better Value Care, viewed 21 May 2020, <https://www.health.
nsw.gov.au/Value/lbvc/Pages/default.aspx>.
COPD, chronic obstructive pulmonary disease.; .
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sustainment of implementing innovations (see online 
supplemental Appendix 1 for implementation outcome 
taxonomy), and are inherently linked to concepts of 
cost- effectiveness (as they are closely related to process 
measures used in economic evaluations and outcomes 
that are valued by patients). A focus on improving these 
outcomes is required to understand how the implementa-
tion and scaling of evidence- based models of care occurs. 
Therefore, it is imperative that we improve our under-
standing of local system dynamics, generative patterns 
of outcomes and conditional causal mechanisms for the 
implementation of large- system, value- based care trans-
formation programmes, to inform health system improve-
ment efforts. The evidence base for how to implement 
change will therefore not take the form of ‘what works’. 
Rather, it will be best placed to achieve broad under-
standing about ‘what tends to work, for whom, in what 
circumstances, how and why’.
Realist study
The level of complexity that is intrinsic to implementing 
large- system, value- based healthcare transformations 
presents a challenge to the use of traditional research 
methods. Healthcare operates in an open system, where 
regularities between events are not necessarily always 
able to be probabilistically specified or measured.29 
Therefore, it is important to apply methodologies that 
situate change as a conditional, contextually dependent 
and time- sensitive processes that occur across multilevel, 
nested and dynamic systems.30 Realist studies, which take 
an approach grounded in the philosophy of scientific 
realism,31 are based on the assumption that programmes 
or initiatives work under certain conditions and are heavily 
influenced by the way that different stakeholders respond 
to them (see glossary of terms; table 3). A form of theory- 
driven research, realist studies seek to understand how a 
programme works, or is expected to work within specific 
contexts, and what conditions may hinder or promote 
successful outcomes.32–34 A realist approach is ideal for 
complex, large- system health system implementation 
programmes,35 as it acknowledges the non- linearity and 
context specificity of change process in complex adaptive 
health systems.36 37 This theory- driven method is increas-
ingly being used for studying the implementation of 
complex interventions within health systems.38
Realist studies assert that programmes to implement 
healthcare improvements are ‘theories incarnate’,34 
that is, the roll out of programmes always has a theoret-
ical underpinning, whether explicit or not. Therefore, 
it is important to make these theories explicit, from the 
perspectives of many actors. These programme theories 
are usually described as configurations between contexts 
(circumstances under which programme implementa-
tion works), mechanisms (generative causes of how imple-
mentation of programmes contribute to benefits) and 
outcomes (the intended consequences of programme 
implementation) (see figure 1 for context–mecha-
nism–outcome (CMO) configuration example. Source: 
Adapted and reproduced from Dalkin et al.39 Use of this 
image is supported by a Creative Commons License, 
http:// creativecommons. org/ licenses/ by/ 4. 0/). When 
focussing on the science around how a programme was 
implemented, rather than the programme itself, there 
are questions as to how ‘outcomes’ should be defined, 
whether to categorise process ‘outputs’ separately from 
outcomes, and which of these to include in a CMO config-
uration. Arguably, configurations of system and imple-
mentation efforts (context, actors, processes, content 
or object of the intervention, and implementation 
outcomes) could be first observed, then assessed on how 
they relate to endpoint patient and health outcomes. The 
process of theory refinement within a realist study would 
ideally inform the way these propositions are configured.
Within a realist paradigm, context is more than a setting 
or place, rather it is anything which influences whether, 
how and why the mechanism will work. The epistemolog-
ical assumption guiding realist studies is that programme 
implementation triggers ‘mechanisms’ of change differ-
ently, depending on the context. In realism, mechanisms 
Table 2 Summary of the multilevel implementation package for the Leading Better Value Care programme
Macro- level policy and 
system drivers
 ► A case for change and shared vision between health leaders across the state health system
 ► Promoting local adaptation and tailoring of programme implementation
 ► Data- driven monitoring and evaluation of progress and outcomes
 ► Provision of initial funding with the intention of local resource prioritisation to ensure 
sustainability
Meso- level implementation 
support agency working 
across health service 
organisations
 ► Promotion of network weaving and extension of collaborations
 ► Providing local technical assistance
 ► Audit and provide feedback
 ► Create a learning collaborative
 ► Promoting adaptability and local tailoring
Hospital- level local 
implementation
 ► Assessment of readiness and identification of barriers and facilitators
 ► Involvement of executive boards
 ► Creation/redesign/restructure of clinical teams
 ► Tailoring of implementation strategies
 ► Capturing and sharing local knowledge
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are considered the ‘underlying entities, processes, or 
social structures which operate in particular contexts to 
generate outcomes of interest’,40 and it is these mecha-
nisms that trigger change rather than the programme 
implementation itself.15 Comparisons between CMO 
configurations can be used to formulate generalisable 
theoretical models (middle- range theories) for how 
and in what circumstances programme implementation 
achieves different outcomes. Delivering transferable 
models for how to implement large- system, value- based 
healthcare initiatives not only benefits ongoing applica-
tion within their current contexts, but can inform how 
improvement initiatives can be scaled to other contexts, 
jurisdictions and settings.
Aims
The aim of this study is to undertake a realist study of the 
implementation of seven value- based healthcare initia-
tives. Specifically, we will develop and refine programme 
theories that unpack how varying strategies, contextual 
features and change mechanisms led to different imple-
mentation and programme outcomes. From this, we 
will build a nuanced model of the factors, conditions 
and levers that stimulate and inform the spread of local, 
multiagency, evidence- informed improvement projects 
into sustainable, nationwide impacts. These aims will be 
achieved by answering the research question: When imple-
menting a large- system, state- wide value- based care programme to 
reduce unwarranted variation and improve patient- centred care, 
what tends to work, how, why, for whom, to what extent and in 
what circumstances, over what duration? The specific objec-
tives of the study are to:
1. Identify the change strategies, processes and theorised 
mechanisms through which implementation of the 
seven value- based care initiatives influenced imple-
mentation and programme outcomes.
2. Investigate the impact of different contextual circum-
stances and agents on the mechanisms of initiative im-
plementation over varying timelines.
Table 3 Glossary of key terms for implementation science, complexity theory and realist studies
Implementation science The scientific study of processes to translate research evidence into practice, understanding what 
influences translational outcomes, and evaluating the adoption of interventions.26
Implementation outcome The effects of deliberate actions to implement an innovation.28
Complexity The behaviour embedded in highly composite systems or models of systems with large numbers of 
interacting components26; the complexity of a behaviour is equal to the length of its description.77
Adaptation The capacity to adjust to internal and external circumstances; usually thought of in terms of 
modifying behaviours over time.26
Systems A group of interacting elements that form a unified functional whole.26
Complex adaptive 
system
A dynamic, self- similar collective of interacting, adaptive agents and their artefacts.26
Realist study A theory- driven approach based on a realist philosophy of science that is used to evaluate ‘what 
works, for whom, under what circumstances and how’ under the assumption that complex 
programmes and interventions work differently under certain circumstances.31 34 41
Programme theory Description of what is supposed to be carried out in the implementation of programmes (theory of 
action) and how and why that is expected to work (theory of change).78 79
Context–mechanism–
outcome configuration
Proposition- building set of possible explanatory relationships between the components of realist 
studies: (C) context or circumstances; (M) mechanisms or underlying social processes; (O) outcomes 
or results.80 81
Middle- range theory Consist of limited sets of assumptions from which specific hypotheses are logically derived 
and confirmed by empirical investigation.82 These theories are considered more abstract and 
generalisable than ‘programme theories’ but do not constitute a ‘grand social theory’ themselves, 
instead they are considered adaptive and cumulative explanations.
Figure 1 Example context–mechanism–outcome configuration for why UK primary care practices placed fewer patients with 
non- cancer illness on their palliative care integrated care pathway register, compared with those with cancer illness.
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3. Develop macro- level, meso- level and micro- level imple-
mentation models for successful value- based initiatives 
in healthcare, based on a mix of implementation strat-




This study will apply an exploratory, sequential, mixed 
methods realist study design, following the RAMESES II 
(Realist And Meta- narrative Evidence Syntheses: Evolving 
Standards) reporting standards for realist studies.41 Data will 
be collated from numerous sources to posit, test and refine 
hypothesised theories for how implementation strategies 
and processes lead to intended or unintended outcomes, 
depending on the influence of various contextual factors 
(eg, structure, relations, culture).42–45 We will use both qual-
itative and quantitative data to uncover these patterns of 
outcomes in different contexts and to explicate the mech-
anisms for implementing value- based healthcare initiatives. 
Our iterative, three- stage model is depicted in figure 2 
(Source: Adapted from Pawson et al,34 Panmunthygala et 
al,46 CMO: context–mechanism–outcome). Table 4 shows 
the three stages of the study and summarises each stage’s 
objective, the focal outcomes, sources of data and analysis 
approaches. Data collection for this study will commence in 
November 2020 and will be completed by July 2022.
Stage 1: identifying the initial programme theories
In stage 1, we will identify initial theories for how the 
value- based care initiatives are implemented into routine 
care. This stage will be informed by a realist synthesis of 
the literature around large- system hospital interventions 
(in preparation). Realist,47 48 exploratory semistructured 
interviews with programme implementers and evalua-
tors, and analysis of documents from the macro- level and 
meso- level implementation support agencies will be used 
to map the actual process of implementation as it was 
done (work as done), compared with how it was planned 
(work as imagined).49 This information will be used to 
refine existing programme logics and process models50 
for the implementation of value- based care initiatives. 
Additionally, relevant aspects of the social and environ-
mental context will be collated and developed during the 
interviews and document review into determinant frame-
works50 to structure the analysis of the hypothesised CMO 
configurations. Through this mapping exercise, we will 
uncover the underlying system dynamics (relationships 
between agents, their attributes and rules of behaviour, 
network structure, feedback loops) that influence the 
implementation.
Stage 2: testing the hypothesised programme theories
During stage 2, focus will shift from developing theo-
ries, to testing theories and refining meta- narratives for 
the configuration of implementation support across 
initiatives. A mixed method approach using realist, 
exploratory semistructured interviews with local hospital 
network staff, quantitative project evaluation data and 
implementation outcome measure surveys will be used to 
test and refine CMOs, constructed in stage 1. This stage 













Identifying the programme 
theory
Review of academic literature, program 
documents, and interviews with 
implementation and evaluation staff
Stage 2
Testing the programme theory
Study design: Mixed methods using 
seven natural experiments
Data collection: 
• Interviews with local hospital staff
• Program evaluation data from 
partner organisations and hospital 
administrative systems




• Qualitative data analysed 
retroductively using CMO 
configuration tool
• Quantitative data analysed using  
regression based approach
• Triangulation of qualitative and 
quantitative data to refine CMOs 
into program theories for initiatives
Stage 3
Translating CMOs into 
generalisable theories
Data synthesis: 
• Key stakeholder feedback and cross-
case comparisons
Figure 2 Three stages of the realist study and proposed process. CMO, context–mechanism–outcome configurations.
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quantitative datasets) model, integrating and merging 
separately analysed data through side- by- side compar-
ison and contrast.51–54 The convergent model will include 
capturing narrative and experiential information from 
local hospital network staff to highlight the mechanisms 
of implementation in different contexts, and variations 
in outcomes from the value- based care initiatives. These 
will be tested against the hypothesised initial programme 
theories, by eliciting comments to confirm, deny and 
refine aspects of the theory. Concurrent to these qualita-
tive approaches, we will examine the quantitative relation-
ships between implementation processes and the relevant 
implementation and programme outcomes for different 
populations, circumstances and time points, according to 
the programme theories. Explicating these relationships 
between variables will build on the structure and process 
models created in stage 1, to articulate generative or condi-
tional causal models.55
Stage 3: translating CMOs into generalisable theoretical models for 
implementation (middle-range theories)
The process of testing programme theories in stage 2 will 
lead to the refinement of CMOs for the seven value- based 
care initiatives, which will be translated into generalisable 
theoretical models (middle- range theories) for imple-
menting large- system, value- based care programmes in 
stage 3. The process of translation will begin by presenting 
and defending CMOs with key stakeholders. Further 
testing will be undertaken by explicitly seeking discon-
firming or contradictory data and considering other 
interpretations that might account for the same find-
ings. Cross- case comparisons will then be used to deter-
mine how the same mechanism could produce different 
outcomes in different contexts and settings. The research 
team will review our realist findings for each initiative 
(including programme theories and CMO configura-
tions) ‘vertically’ to identify common thematic elements 
according to context, mechanism and outcomes. Data 
will also be analysed across case studies ‘horizontally’ to 
uncover potentially generative causal patterns or regu-
larities between mechanism and outcomes under certain 
contextual conditions. This process will eventually trans-
late the specifics of each individual initiative to more 
analytically generalised abstract theories.
Qualitative methods
Qualitative sampling and recruitment procedures
A purposive sample supported by snowballing will iden-
tify respondents best placed to cast light on the proposed 
programme theories. Interview invitation emails will be 
distributed from the investigators via the state- wide imple-
mentation support agencies and local hospital networks 
to identified staff involved in the implementation of initia-
tives. We intend to interview up to 30 implementers and 
evaluators from the programme implementation support 
agencies for stage 1, and up to 30 local hospital network 
staff in stage 2 (see table 4 outlining the data source for 
each stage). Realist studies rely less on the concept of data 
saturation because realist hypotheses are confirmed or 
abandoned using a multi- method strategy for relevance 
and rigour.31 56 Our iterative process of data collection 
will include the possibility of re- interviewing participants 
to further develop our programme theories as we become 
more knowledgeable about the programme through 
refinement against other data (documentary, interviews 
with other stakeholders and quantitative findings).34 48 57 
Specific inclusion and exclusion criteria are provided in 
online supplemental Appendix 2.
Table 4 Relationship between data source, analysis approaches and research objectives
Stage Data source Data analysis Objectives
1 Qualitative:
 ► Interviews with programme 
designers, supporting 
and evaluation staff from 
implementation support agencies
 ► Public and internal programme 
documents
Qualitative:
 ► Retroductive, theory- driven 
realist analysis
 ► Documentary analysis
(a) Identify the change strategies, processes 
and theorised mechanisms through which 
implementation of the seven value- based 
care initiatives influenced implementation and 
programme outcomes.
(b) Investigate the impact of different contextual 
circumstances and agents on the mechanisms 
of initiative implementation over varying 
timelines.
2 Qualitative:
 ► Interviews with local hospital 
network staff
Quantitative:
 ► Programme evaluation data
 ► Hospital administrative data
 ► Implementation outcome surveys
Qualitative:
 ► Retroductive, theory- driven 
realist analysis
Quantitative:
 ► Descriptive and inferential 
statistical analysis
3 Data from stage 1, 2 and 3 Mixed methods:
 ► Realist triangulation
(c) Develop macro- level, meso- level and micro- 
level implementation models for successful 
value- based initiatives in healthcare, based 
on a mix of implementation strategies and 
mechanisms in specific contexts that achieve 
desired implementation outcomes.
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Qualitative data collection
The realist interview builds knowledge of why there is 
variation around what happens in natural settings which 
helps develop, test and refine theories. The interviewer–
interviewee relationship adopts the teacher–learner cycle 
beginning with the interviewer teaching ‘the particular 
programme theory under test’ to the interviewee and 
then ‘the respondent, having learnt the theory under test, 
is able to teach the interviewer about the components of a 
programme in a particularly informed way’.58 Interviews 
will take place either face- to- face at the interviewee’s 
workplace or a mutually agreed location via telephone or 
videoconference, depending on the participants’ prefer-
ences. The interview guides will be pilot tested with two 
stakeholders. Interviews will be approximately 30–45 min 
in duration, undertaken by three experienced quali-
tative researchers (MNS, EFA, CP). Information from 
public and internal programme documents that is rele-
vant to the implementation of the seven value- based care 
initiatives will be reviewed to inform the development of 
programme theories.
Qualitative data analysis
All audio recordings will be transcribed verbatim and 
entered into NVivo V.12 for data management.59 Analysis 
will be undertaken by multiple researchers conducting 
the interviews, in a concurrent and continuous manner 
alongside data collection. Ongoing analysis work ensures 
early immersion in the data.33 Consistent with realist 
approaches, data analysis will be retroductive in that it 
will oscillate between an inductive and deductive logic 
to multiple data sources, as well as incorporating the 
researchers’ own insights of generative causation for the 
programme theories.60 After data collection, qualitative 
analysts will read through, and systematically analyse 
each transcript individually before engaging in group 
work consensus- building around CMOs and causal 
explanations.61 Qualitative analysts will then revisit our 
programme theories and refine these in the light of CMO 
data. Programme documents will be analysed alongside 
interview transcripts in NVivo to confirm or disconfirm 
our CMOs, ensuring a diversity of data sources and 
another level of clarification.
Quantitative methods
Programme evaluation data
Evaluation data relating to the implementation outcomes 
of value- based care initiatives and contextual factors 
impacting these processes will be accessed by researchers 
with institutional approval from the partner organi-
sations. These data will be sourced from programme 
roadmap milestone measures, performance reporting 
systems, fidelity audits, hospital culture surveys, patient 
and carer surveys, and quality of life measures. Deiden-
tified routinely collected administrative data related to 
programme implementation (eg, clinical processes indic-
ative of implementation fidelity) will be collected from 
the Enterprise Data Warehouse for Analysis Reporting 
and Decisions (EDWARD), which is mandated business 
intelligence standard focused on reports for NSW Health 
Local Health Districts in running their operations. The 
specific outcomes of interest will be identified during 
stage 1 of the realist study pending both access and quality 
of available data.
Implementation outcome measure survey
The Acceptability of Intervention Measure (AIM), Inter-
vention Appropriateness Measure (IAM) and Feasibility 
of Intervention Measure (FIM)62 will be administered 
via survey at a single time point across all local hospital 
networks. These measures include four simple ques-
tions at fifth grade readability level and do not require 
any specialist training to administer, score or inter-
pret. Items are measured on a five- point Likert scale 
and scores are calculated as a mean. The AIM, IAM 
and FIM each demonstrate strong psychometric prop-
erties.62 Local hospital network staff involved in the 
implementation of initiatives will be invited to take part 
in the survey in an email distributed by the researchers, 
via the programme implementation support agencies. 
The survey will be administered online, using REDCap 
(Research Electronic Data Capture) tools hosted at 
Macquarie University.63
Quantitative data analysis
Statistical analyses will be conducted using commonly 
available software packages to explore the impact of 
implementation strategies and processes on a range of 
implementation and programme outcomes which will be 
identified during stage 1 of the realist study depending on 
the access to and quality of data. Descriptive statistics will 
be used to present continuous data as mean and standard 
deviation (SD), median and (inter- quartile range (IQR), 
or sample maximum and minimum, and categorical 
data as frequencies and proportions. For the purposes of 
this realist study, programme implementation strategies 
and processes will generally be categorised as indepen-
dent variables, where implementation and programme 
outcomes will be categorised as dependent variables. 
Interaction effects will be considered where appropriate.
Patient and public involvement
The views of Australian public representatives from the 
NSW Ministry of Health and implementation support 
agencies were incorporated into the design of the study, 
from the stage of research grant funding application. 
The research questions and observations of interest were 
co- developed in consultation with the project partners, 
informed by their experience implementing the initia-
tives of interest for this study protocol. A Project Advisory 
Group was established with representatives from local 
hospital networks to support the design and recruitment 
process for the study, minimise time burden for partici-
pation and identify pathways for disseminating findings 
across the health system.
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ETHICS AND DISSEMINATION
Ethical approval has been granted by Macquarie Univer-
sity (Project ID 23816) and Hunter New England Human 
(Project ID 2020/ETH02186) Research Ethics Commit-
tees . All interview participants will receive written infor-
mation and provide informed consent prior to data 
collection taking place (online supplemental Appendix 
3). All interview participants will be assured of anonymity 
and confidentiality during all data management, handling 
and reporting processes. Ethical considerations regarding 
the use of routinely collected administrative data where 
it is impractical to obtain individual informed consent 
will be managed in accordance with the National Health 
and Medical Research Council (NHMRC) National State-
ment on Ethical Conduct in Human Research (2007)—
Updated 2018.64
Data storage and retention
Electronic data will be stored on a password- protected 
university server and accessible only to members of the 
study team. Hard copy data will be stored in locked 
cabinets within secure offices. Data will be destroyed 
seven years after the date of the final peer- reviewed publi-
cation, in accordance with ethical guidelines.
Dissemination
A series of roundtables will be conducted across Common-
wealth, State and Territory health systems in Australia to 
extend the benefits from this programme of work. Special 
attention will be paid to hospitals, local hospital networks 
and States as health systems managers. The results from 
this project will be submitted for publication in peer- 
reviewed academic journals and will be presented at 
conferences and seminars with identifiable information 
omitted.
DISCUSSION
This realist study will support the implementation of 
value- based healthcare improvement initiatives, by lever-
aging our understanding of complex adaptive systems,65 66 
evidence- based medicine67 and the emerging science of 
implementation.68 69 Successful systems- wide improve-
ment depends on identifying, learning and capturing 
the benefits from local innovation and understanding 
that, in complex systems, local contexts are critical to 
success.24 70–73 Our investigation of programme imple-
mentation in varying populations, circumstances and 
time points will deliver a transferable model for imple-
menting large- system improvements in healthcare. This 
evidence- based ‘road map’ of implementation practices is 
expected to enable local successes to be effectively trans-
lated into meaningful, systems- wide change.
Realist studies are based on the premise that it is not 
possible to create and measure entirely closed system 
experiments for healthcare research in real- world condi-
tions. Protocols for controlled trials are usually produced 
to reduce the risk of outcome and reporting bias in the 
evaluation,74 75 and to enable replication.76 However, it 
is not possible to describe every detail of a realist study 
in advance, as their iterative and exploratory nature 
mean that important factors for examination emerge as 
theory develops.41 Therefore, protocol deviation in realist 
studies does not necessarily constitute a risk of bias, given 
the inherent flexibility of realist study design. This realist 
study protocol will ensure rigour in planning, provide 
transparency of approach, support ethical consider-
ations and demonstrate realist assumptions in our project 
conception.
An important consideration for our realist study is 
articulating the bounds of inquiry and finding a level of 
abstraction that allows the building of theories that are 
generalisable to other settings and implementation of 
similar programmes. This work focuses specifically on 
the implementation of seven LBVC initiatives, which 
have consistent overarching goals and a suite of imple-
mentation strategies. The proposed realist study will only 
provide insights towards the science and practice of imple-
mentation and will not necessarily articulate the overall 
benefit or value of the identified initiatives. A parallel 
investigation is being conducted by the project team to 
identify, measure and test an economic benefits measure-
ment framework for value- based healthcare, using these 
initiatives, that articulates the value from expected health 
outcomes and preferences for experience and equity 
(Partington et al, forthcoming). It is intended that the 
realist study outputs will be at a level of abstraction that 
allows observations ‘across’ programmes to see where 
mechanisms are operating, and how different contexts 
for them lead to other outcomes, thereby supporting 
generalisation.
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